TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14710104

Group type: EXPERIMENTAL
Intervention: Prenatal vitamin with 400 IU of vitamin E and 500 mg of vitamin C
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (prenatal vitamin without additional vitamins)
Number of subjects: 20
Study: 11008978

Group type: EXPERIMENTAL
Intervention: HELIOX (80% helium, 20% oxygen)
Number of subjects: 50

Group type: COMPARATOR
Intervention: AIR (compressed room air)
Number of subjects: 50
Study: 8997675

Group type: EXPERIMENTAL
Intervention: Mechanical fixation method
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Optical method
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Automated method
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference point-based method
Number of subjects: 20
Study: 1361814

Group type: EXPERIMENTAL
Intervention: UV-Flash system
Number of subjects: 46

Group type: COMPARATOR
Intervention: Disconnect system
Number of subjects: 46
Study: 31562517

Group type: EXPERIMENTAL
Intervention: Educational activities at 2-3 years
Number of subjects: 4253

Group type: EXPERIMENTAL
Intervention: Play at 2-3 years
Number of subjects: 4253

Group type: EXPERIMENTAL
Intervention: Play at 4-5 years
Number of subjects: 4253

Group type: COMPARATOR
Intervention: Screen time at all ages
Number of subjects: 4253
Study: 29655277

Group type: EXPERIMENTAL
Intervention: Low-intensity interprofessional supportive care in cancer (LI‐IPSC‐C)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: High-intensity interprofessional supportive care in cancer (HI‐IPSC‐C)
Number of subjects: 84
Study: 27318957

Group type: EXPERIMENTAL
Intervention: Antisocial lying group (temptation resistance paradigm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prosocial lying group (undesirable gift scenario)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Girls in prosocial lying
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Boys in prosocial lying
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Computer Expression Recognition Toolbox (CERT)
Number of subjects: 0
Study: 24295556

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate 100 μg once-daily (OD)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 250 μg twice-daily (BD)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate 100 μg OD
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 250 μg BD
Number of subjects: 343

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study: 22408263

Group type: EXPERIMENTAL
Intervention: R-ICE
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: R-DHAP
Number of subjects: 161

Group type: COMPARATOR
Intervention: MYC(+) DLBCL patients
Number of subjects: 161

Group type: COMPARATOR
Intervention: MYC(−) DLBCL patients
Number of subjects: 161
Study: 21430407

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 68
Study: 18384246

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg/day
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Naltrexone 100 mg/day
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Naltrexone 150 mg/day
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Naltrexone (all doses)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 16863894

Group type: EXPERIMENTAL
Intervention: Home communication intervention (HCI) delivered by a telehealth device (Health Buddy) for 12 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Home communication intervention (HCI)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (HHC only)
Number of subjects: 50
Study: 12588464

Group type: EXPERIMENTAL
Intervention: Sumatriptan (SUM) 6 mg s.c. injected in the morning and afternoon
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 10960002

Group type: EXPERIMENTAL
Intervention: Porous coating
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydroxyapatite coating
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetabular augmentation screws or offset acetabular liners
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Offset acetabular liners
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Survivors
Number of subjects: 0
Study: 9303395

Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg once daily)
Number of subjects: 590

Group type: COMPARATOR
Intervention: Ceftriaxone and/or cefuroxime axetil (1 to 2 g once to twice daily and 500 mg twice daily respectively)
Number of subjects: 590

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 590

Group type: COMPARATOR
Intervention: Ceftriaxone and/or cefuroxime axetil
Number of subjects: 590
Study: 8347269

Group type: EXPERIMENTAL
Intervention: Cyclosporin (10 mg/kg p.o.) administered 12 hours post-operatively
Number of subjects: 53

Group type: COMPARATOR
Intervention: Cyclosporin (10 mg/kg p.o.) administered 6 hours prior to transplant surgery
Number of subjects: 53
Study: 3010693

Group type: EXPERIMENTAL
Intervention: Epinephrine infusion
Number of subjects: 9

Group type: COMPARATOR
Intervention: Atenolol (beta‐adrenoceptor antagonist)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Timolol (non-selective beta blocker)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Propranolol (non-selective beta blocker)
Number of subjects: 9
Study: 30219705

Group type: EXPERIMENTAL
Intervention: Doxofylline 400 mg
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Theophylline 250 mg
Number of subjects: 483

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 483
Study: 27620393

Group type: EXPERIMENTAL
Intervention: Severe Hypertension
Number of subjects: 987

Group type: COMPARATOR
Intervention: Less Tight Control
Number of subjects: 987
Study: 24480160

Group type: EXPERIMENTAL
Intervention: Curiam BT clinical decision support system
Number of subjects: 55

Group type: COMPARATOR
Intervention: Magnetic resonance imaging (MR)
Number of subjects: 55
Study: 22805388

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (rhGH) therapy, administered three-times weekly for one year
Number of subjects: 15

Group type: COMPARATOR
Intervention: No rhGH therapy (year before treatment)
Number of subjects: 15
Study: 20038733

Group type: EXPERIMENTAL
Intervention: Axillary Lymph Node Dissection (ALND)
Number of subjects: 566

Group type: COMPARATOR
Intervention: Axillary Radiation Therapy (ART)
Number of subjects: 566
Study: 17991819

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups (CBT and Wait-list)
Number of subjects: 35
Study: 15943596

Group type: EXPERIMENTAL
Intervention: Multifaceted prenatally started intervention strategy including house dust mite impermeable bed coverings, education on breast feeding, hypoallergenic feeding, timing of introduction of solid food, and smoking cessation.
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: Multifaceted prenatally started intervention strategy (high-risk group).
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: Optimized randomized-clinical adherence trial (RCAT) for 92 high-risk infants.
Number of subjects: 843

Group type: COMPARATOR
Intervention: Control group of low-risk infants (308 infants).
Number of subjects: 843
Study: 12775858

Group type: EXPERIMENTAL
Intervention: Prophylactic group (allergen avoidance measures from birth)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (standard advice)
Number of subjects: 120
Study: 10351970

Group type: EXPERIMENTAL
Intervention: Digoxin (serum concentration, 1.29+/‐0.35 nmol/L)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 43
Study: 7573994

Group type: EXPERIMENTAL
Intervention: Perivenous technique (Group 2)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Selander technique (Group 1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 36
Study: 2008268

Group type: EXPERIMENTAL
Intervention: Argon laser treatment
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Xenon photocoagulation treatment
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control eyes (not treated with argon or xenon)
Number of subjects: 151
Study: 6750675

Group type: EXPERIMENTAL
Intervention: Oxazepam (N = 108)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo (N = 112)
Number of subjects: 220
Study: 30943337

Group type: EXPERIMENTAL
Intervention: Benralizumab (30 mg, three monthly subcutaneous injections)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Benralizumab (during open-label phase)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Benralizumab
Number of subjects: 20
Study: 28730694

Group type: EXPERIMENTAL
Intervention: RG7697 (0.25-2.5 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: RG7697 (≥0.75 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: RG7697 (2.5 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: RG7697 (≥1.1 mg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 25773939

Group type: EXPERIMENTAL
Intervention: Entire microcoil implantation method (performed for 51/99 nodules)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Leaving-microcoil-end implantation method (performed for 48/99 nodules)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: CT-guided microcoil implantation
Number of subjects: 92
Study: 22951345

Group type: EXPERIMENTAL
Intervention: Amniotic membrane dressing
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 38
Study: 21777555

Group type: EXPERIMENTAL
Intervention: Itopride (prokinetic agent) with a PPI
Number of subjects: 100

Group type: COMPARATOR
Intervention: PPI and placebo
Number of subjects: 100
Study: 19262420

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional approaches
Number of subjects: 50
Study: 16876132

Group type: EXPERIMENTAL
Intervention: Bupropion and counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 0
Study: 14581124

Group type: EXPERIMENTAL
Intervention: Oral delta-9-THC 5 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10933104

Group type: EXPERIMENTAL
Intervention: AM‐MDPI at flow rate 54 L x min(‐1)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Turbuhaler at flow rate 58 L x min(‐1)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: AM‐MDPI at high flow rate 99 L x min(‐1)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: AM‐MDPI at flow rate 65 L x min(‐1)
Number of subjects: 13
Study: 8932993

Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 12
Study: 1567148

Group type: EXPERIMENTAL
Intervention: Bupivacaine instillation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Inguinal field block
Number of subjects: 50
Study: 3929301

Group type: EXPERIMENTAL
Intervention: d-amphetamine (AMP; 10 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: d-amphetamine (AMP; 2.5 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: diazepam (10 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 17
Study: 29745441

Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (OACs) prescribed at hospital discharge
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Factors associated with patient frailty
Number of subjects: 328
Study: 26354036

Group type: EXPERIMENTAL
Intervention: Frog storybooks (various stories)
Number of subjects: 831
Study: 24666210

Group type: EXPERIMENTAL
Intervention: Spirometry testing before and after bronchodilator (BD) using the EasyOne spirometer.
Number of subjects: 5176

Group type: COMPARATOR
Intervention: Post-BD test sessions
Number of subjects: 5176
Study: 22686204

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg daily for 1 year)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no metformin)
Number of subjects: 39
Study: 20115975

Group type: EXPERIMENTAL
Intervention: Endoscopic Sinus Surgery Simulator (ES3) training
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control novice residents
Number of subjects: 25
Study: 18062520

Group type: EXPERIMENTAL
Intervention: Midazolam 0.03 mg/kg followed by pethidine 20 mg intravenously
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midazolam 0.03 mg/kg followed by tramadol 20 mg intravenously
Number of subjects: 40
Study: 15691267

Group type: EXPERIMENTAL
Intervention: Tac/MMF/S
Number of subjects: 489

Group type: COMPARATOR
Intervention: Tac/Aza/S
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Tac/MMF
Number of subjects: 489

Group type: COMPARATOR
Intervention: Tac/Aza
Number of subjects: 489
Study: 12666828

Group type: EXPERIMENTAL
Intervention: 400 microg Se-methionine daily, increased fish intake (at least three fish dinners weekly)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 400 microg selenite daily, increased fish intake (at least three fish dinners weekly)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo tablets, increased fish intake (at least three fish dinners weekly)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No selenium supplementation, increased fish intake (at least three fish dinners weekly)
Number of subjects: 32
Study: 10480522

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg t.i.d.)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg/day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 8761775

Group type: EXPERIMENTAL
Intervention: 0.1 p. 100 adapalene gel
Number of subjects: 89

Group type: COMPARATOR
Intervention: 0.03 p. 100 adapalene gel
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 0.025 p. 100 tretinoin gel
Number of subjects: 89
Study: 2116634

Group type: EXPERIMENTAL
Intervention: Self-help smoking cessation program (printed materials received through the mail)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 100
Study: 6118121

Group type: EXPERIMENTAL
Intervention: 50 mg atenolol for 3 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fenethylline-hydrochloride, diazepam, oxazepam, and alcohol
Number of subjects: 40
Study: 31731134

Group type: EXPERIMENTAL
Intervention: Prefabricated foot orthoses
Number of subjects: 21

Group type: COMPARATOR
Intervention: Flat shoe inserts
Number of subjects: 21

Group type: COMPARATOR
Intervention: Own shoes
Number of subjects: 21
Study: 31752771

Group type: EXPERIMENTAL
Intervention: MBM intervention (mobile phone application for women and clinician education)
Number of subjects: 256700

Group type: EXPERIMENTAL
Intervention: MBM intervention
Number of subjects: 256700
Study: 28679413

Group type: EXPERIMENTAL
Intervention: Double carbapenem (DC) regimen
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard treatment (ST)
Number of subjects: 144
Study: 26040181

Group type: COMPARATOR
Intervention: LASIK treatment
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: PRK treatment
Number of subjects: 68
Study: 25099185

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (1000 mg, once daily) and prednisolone (5 mg, twice daily)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate and prednisolone
Number of subjects: 82
Study: 22965975

Group type: EXPERIMENTAL
Intervention: Medical Treatment (MT)
Number of subjects: 611

Group type: COMPARATOR
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 611

Group type: COMPARATOR
Intervention: Coronary Artery Bypass Graft (CABG)
Number of subjects: 611
Study: 19442491

Group type: EXPERIMENTAL
Intervention: Immediate discontinuation of current antipsychotic with aripiprazole (10 mg)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Tapering off current antipsychotic over 4 weeks with aripiprazole (10 mg)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Tapering off current antipsychotic over 6 weeks with aripiprazole (10 mg)
Number of subjects: 77

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 77
Study: 17880369

Group type: EXPERIMENTAL
Intervention: 2.0 g agar
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 5.2 g pectin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control meal (fibre-free meal)
Number of subjects: 10
Study: 15336581

Group type: EXPERIMENTAL
Intervention: Physician reminders recommending documentation of advance directives
Number of subjects: 1079

Group type: EXPERIMENTAL
Intervention: Physician reminders plus mailing advance directives to patients with educational literature
Number of subjects: 1079

Group type: COMPARATOR
Intervention: Control group (neither intervention)
Number of subjects: 1079
Study: 11257337

Group type: COMPARATOR
Intervention: CAIV-T vaccine
Number of subjects: 6163
Study: 9557039

Group type: EXPERIMENTAL
Intervention: Tesio catheter (TC) for long-term hemodialysis
Number of subjects: 26
Study: 7738212

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Indapamide
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 19
Study: 2563000

Group type: EXPERIMENTAL
Intervention: Chorionic villus sampling (CVS)
Number of subjects: 2787

Group type: COMPARATOR
Intervention: Amniocentesis
Number of subjects: 2787
Study: 387824

Group type: EXPERIMENTAL
Intervention: 30 ppm formaldehyde solution applied in an axilla for 2 weeks (double-blind controlled test)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Closed patch test with 30 ppm formaldehyde for 120 continuous hours
Number of subjects: 13
Study: 31958404

Group type: EXPERIMENTAL
Intervention: Six-component intervention package (refresher training for providers, counselling tool, supportive supervision, daily availability of contraceptive services, client appointment cards, invitation letters for partners)
Number of subjects: 576

Group type: COMPARATOR
Intervention: Standard antenatal and postnatal care (control group)
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Six-component intervention package
Number of subjects: 576
Study: 31729989

Group type: EXPERIMENTAL
Intervention: IWB/CRL + CM
Number of subjects: 80

Group type: COMPARATOR
Intervention: CM-only
Number of subjects: 80
Study: 27469421

Group type: EXPERIMENTAL
Intervention: Personal support lifestyle education programme (PSMetS)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 193
Study: 25881802

Group type: EXPERIMENTAL
Intervention: Early corticosteroid withdrawal (CSWD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chronic corticosteroids (CCS)
Number of subjects: 0
Study: 24202191

Group type: EXPERIMENTAL
Intervention: Smoked cannabis joint (11% Δ9-THC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regular smokers
Number of subjects: 0
Study: 22324182

Group type: EXPERIMENTAL
Intervention: Systemic-psychomotor family counselling (PsyFam; based on symbolic play)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systemic family therapy (SB; exclusively verbal)
Number of subjects: 0
Study: 19415994

Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT(4)) treatment in OH group
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT(4)) treatment in SH group
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (EU women)
Number of subjects: 103
Study: 17059616

Group type: EXPERIMENTAL
Intervention: General anaesthesia with local anaesthetic infiltration
Number of subjects: 0

Group type: COMPARATOR
Intervention: General anaesthesia with placebo infiltration
Number of subjects: 0
Study: 15936120

Group type: EXPERIMENTAL
Intervention: OPV produced on MRC-5 cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: OPV produced on PMKC cells
Number of subjects: 0
Study: 14640854

Group type: EXPERIMENTAL
Intervention: Cognitive function assessment at 6 days post-surgery
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Cognitive function assessment at 8 weeks post-surgery
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Cognitive function assessment at 5 years post-surgery
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Microemboli recorded during surgery
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Postoperative short-term cognitive change
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Degree of recovery at 8 weeks
Number of subjects: 107
Study: 10921125

Group type: EXPERIMENTAL
Intervention: Abstinence capsule
Number of subjects: 435

Group type: COMPARATOR
Intervention: Lofexidine
Number of subjects: 435
Study: 7791587

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation at 20% of maximum voluntary isometric contraction (MVC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation at 50% of maximum voluntary isometric contraction (MVC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation at 80% of maximum voluntary isometric contraction (MVC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Electrically elicited fatigue tests at 20 pps with 20% MVC
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Electrically elicited fatigue tests at 40 pps with 20% MVC
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Electrically elicited fatigue tests at 60 pps with 20% MVC
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Electrically elicited fatigue tests at 20 pps with 50% MVC
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Electrically elicited fatigue tests at 40 pps with 50% MVC
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Electrically elicited fatigue tests at 60 pps with 50% MVC
Number of subjects: 50
Study: 1828417

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thiazide diuretics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ca2(+)‐channel blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alpha-blockers
Number of subjects: 0